How to Help Your Patients Save Money on Insulin Analog, Lispro Mixed: A Provider's Guide to Savings Programs

The retail cost of Insulin Analog, Lispro Mixed can be a barrier to adherence — and poor adherence leads to preventable hospitalizations, complications, and worse outcomes. Fortunately, in 2026, the savings landscape for this medication has improved dramatically. This guide gives you a clear, practice-ready summary of every major cost reduction program available for your patients, organized by insurance status.

Why Cost Still Matters Even After Lilly's Price Reductions

Eli Lilly has made significant list price reductions on its insulin products. However, the retail cash price for Humalog Mix 75/25 without insurance or a discount program can still reach $150–$280 per 10 mL vial. For patients on fixed incomes, those with high-deductible plans, or those in coverage gaps, these costs remain prohibitive. Studies show that approximately 1 in 6 adults with diabetes rationed their insulin due to cost — a dangerous and entirely preventable behavior.

For Commercially Insured Patients: The Lilly Insulin Value Program

The Lilly Insulin Value Program caps all Lilly insulin products — including Humalog Mix 75/25 and Mix 50/50 — at $35 per month for patients with commercial insurance. The $35 cap applies to all covered Lilly insulins in a single month, not $35 per product.

How patients access it: Direct patients to insulins.lilly.com to download the savings card. The card is presented at participating pharmacies at the time of fill. The discount typically applies automatically at major chain pharmacies — no prior enrollment in many cases.

Eligibility: Commercially insured patients. Not valid for Medicare, Medicaid, Tricare, VA, or any other government-funded insurance.

For Uninsured Cash-Pay Patients: $35/Month Through Lilly

The same Lilly Insulin Value Program also applies to patients paying cash without any insurance. Uninsured patients who access the program at participating pharmacies pay no more than $35 per month for all their Lilly insulin prescriptions combined. This is one of the most impactful programs for vulnerable patients and is worth mentioning at every diabetes visit for uninsured patients.

For Medicare Patients: The Inflation Reduction Act $35 Cap

Since January 2023, Medicare Part D enrollees pay no more than $35 per month per covered insulin under the Inflation Reduction Act (IRA). This cap applies regardless of the plan's formulary tier for Humalog Mix — even if it is on a non-preferred tier, the patient still pays no more than $35.

No coupon or separate enrollment is required for the IRA cap — it is built into Medicare Part D law. If a patient reports paying more than $35 per month per insulin under Medicare, advise them to contact their Part D plan for a potential refund.

For Low-Income Uninsured Patients: Lilly Cares Foundation Patient Assistance Program

For patients who are uninsured, underinsured, or unable to afford their insulin even with discount programs, the Lilly Cares Foundation Patient Assistance Program provides free insulin. Applications are submitted by the prescribing physician and require documentation of income and lack of coverage. Visit lillycares.com for application forms and income eligibility thresholds.

Approval typically takes 2–4 weeks. For patients in immediate need, the Lilly Insulin Value Program ($35/month) is the faster bridge while a patient assistance application is processed.

Pharmacy Coupons as a Supplement: GoodRx and Competitors

For patients who cannot access the Lilly savings card (e.g., those at pharmacies not participating in Lilly's program, or who need to fill quickly at a non-preferred location), GoodRx coupons can reduce the cost of Insulin Lispro 75/25 to approximately $81.36 — a 64% reduction from the retail average. GoodRx cannot be combined with insurance but can be combined with the Lilly cash program.

SingleCare.com and RxSaver.com are GoodRx competitors worth checking — prices at specific pharmacies may be lower than GoodRx for certain patients.

Mail Order: Maximizing Insurance Benefits

For patients with commercial insurance, prescribing 90-day supplies through mail-order pharmacies can reduce insulin costs by 20–40% versus monthly retail fills, depending on plan design. Mail-order also typically provides better stock reliability for insulin products than retail pharmacies, reducing the likelihood of availability gaps for your patients.

When writing insulin prescriptions, consider specifying "dispense 90-day supply" or "may fill as 3-month supply via mail-order" to make it easier for patients to take advantage of this option.

Quick Reference: Savings Programs by Patient Type

Commercially insured: Lilly Insulin Value Program → $35/month cap (insulins.lilly.com)

Uninsured cash-pay: Lilly Insulin Value Program → $35/month cap; or GoodRx coupon → ~$81/vial

Medicare Part D: IRA insulin cap → $35/month (no coupon needed; built into law)

Low-income uninsured: Lilly Cares Foundation → free insulin (lillycares.com); physician-submitted application required

Addressing Both Cost and Access in Your Practice

Cost and access are related but distinct challenges. A patient who can afford their insulin but can't find it in stock needs a different solution than one who can find it but can't pay for it. medfinder for providers helps with the access problem — patients can use it to find nearby pharmacies with stock. For context on why insulin lispro mixed has been difficult to find, read: Insulin Analog, Lispro Mixed Shortage Update: What Patients Need to Know in 2026.